Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsy

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 363-368

  Koshenkov, Vadim P ^a,d   Shulkin, Daniel ^b   Bustami, Rami ^c   Chevinsky, Aaron H ^a   Whitman, Eric D ^a,b,c  

^a Atlantic Health   (United States)

^b Carol G Simon Cancer Center   (United States)

^c Atlantic Center for Research   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

breslow thickness; indeterminate thickness; sentinel lymph node biopsy

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ARTICLE; BRESLOW THICKNESS; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CUTANEOUS MELANOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SKIN SURGERY; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84865146927     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23093     Document Type: Article

References (28)

1. Rigel DS, Friedman RJ, Kopf AW:, The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. J Am Acad Dermatol 1996; 34: 839-847. (Pubitemid 26137214)
2. Consensus Statement, Diagnosis and treatment of early melanoma. NIH Consensus Development Conference January 27-29, 1992.
3. Woods JE, Soule EH, Creagan ET:, Metastasis and death in patients with thin melanoma (less than 0.76 mm). Ann Surg 1983; 198: 63-64. (Pubitemid 13059119)
4. Morton DL, Thompson JF, Essner R, et al.: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230: 453-463.
5. Gershenwald JE, Thompson W, Mansfield PF, et al.: Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-983. (Pubitemid 29109331)
6. Nguyen CL, McClay EF, Cole DJ, et al.: Melanoma thickness and histology predict sentinel lymph node status. Am J Surg 2001; 18: 8-11. (Pubitemid 32209113)
7. Clary BM, Brady MS, Lewis JJ, et al.: Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of large single-institutional experience with an emphasis on recurrence. Ann Surg 2001; 233: 250-258. (Pubitemid 32106080)
8. Haddad FF, Stall A, Messina J, et al.: The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999; 6: 144-149. (Pubitemid 29114276)
9. National comprehensive cancer network: Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician-gls/default.asp.
10. Sober AJ, Chuang TY, Duvic M, et al.: Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001; 45: 579-586. (Pubitemid 32917254)
11. Stell VH, Norton HJ, Smith KS, et al.: Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol 2007; 14: 893-898. (Pubitemid 46175340)
12. Greene FL, Page DL, Fleming ID, et al.: AJCC cancer staging manual, 6th edition. Berlin Heidelberg New York: Springer; 2002.
13. Kelemen PR, Essner R, Foshag LJ, et al.: Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma. J Am Coll Surg 1999; 189: 247-252. (Pubitemid 29408860)
14. McKinnon JG, Yu XQ, McCarthy WH, et al.: Prognosis for patients with thin cutaneous melanoma: Long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 2003; 98: 1223-1231. (Pubitemid 37099907)
15. Gimotty PA, Guerry D, Ming ME, et al.: Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 2004; 22: 3668-3676. (Pubitemid 41095205)
16. Mays MP, Martin RC, Burton A, et al.: Should all patients with melanomas between 1 and 2mm Breslow thickness undergo sentinel lymph node biopsy ? Cancer 2010; 116: 1535-1544.
17. Agnese DM, Abdessalam SF, Burak WE Jr, et al.: Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003; 134: 542-548. (Pubitemid 37411959)
18. Bleicher RJ, Essner R, Foshag LJ, et al.: Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 2003; 21: 1326-1331. (Pubitemid 46606411)
19. Wrightson WR, Wong SL, Edwards MJ, et al.: Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003; 10: 676-680. (Pubitemid 40486900)
20. Balch CM, Gershenwald JE, Soong SJ, et al.: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
21. Sondak VK, Taylor JM, Sabel MS, et al.: Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004; 11: 247-258. (Pubitemid 40486764)
22. Bedrosian I, Faries MB, Guerry D 4th, et al.: Incidence of sentinel node metastasis in patients with thin primary melanoma (< ora=1 mm) with vertical growth phase. Ann Surg Oncol 2000; 7: 262-267. (Pubitemid 30318313)
23. Faries MB, Wanek LA, Elashoff D, et al.: Predictors of occult nodal metastasis in patients with thin melanoma. Arch Surg 2010; 145: 137-142.
24. Hemo Y, Gutman M, Klausner JM:, Anatomic site of primary melanoma is associated with depth of invasion. Arch Surg 1999; 134: 148-150. (Pubitemid 29088964)
25. Morton DL, Davtyan DG, Wanek LA, et al.: Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark's level and Breslow thickness. Cancer 1993; 71: 3737-3743. (Pubitemid 23152692)
26. Owen SA, Sanders LL, Edwards LJ, et al.: Identification of higher risk thin melanomas should be based on Breslow depth not Clark's level IV. Cancer 2001; 91: 983-991.
27. Moore P, Hundley J, Hundley J, et al.: Does shave biopsy accurately predict the final breslow depth of primary cutaneous melanoma ? Am Surg 2009; 75: 369-373.
28. Zager JS, Hochwald SN, Marzban SS, et al.: Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. J Am Coll Surg 2011; 212: 454-460.